Cytokinetics Presents Additional 48-Week Data from Forest-Hc

Cytokinetics Presents Additional 48-Week Data from Forest-Hcm, the Open Label Extension Clinical Study of Aficamten, At the American College of Cardiology 73rd Annual Scientific Session

Cytokinetics, Incorporated announced additional 48-week data from FOREST-HCM , the open label extension clinical study of aficamten in patients with hypertrophic cardiomyopathy , at the 73rd Annual...

Related Keywords

, Research Evaluation Of Sustained Treatment , York Heart Association , American College Of Cardiology , Cytokinetics Incorporated , Research Evaluation , Sustained Treatment , Annual American College , Scientific Session , New York Heart Association , Functional Class , Markets ,